IMVT icon

Immunovant

112 hedge funds and large institutions have $238M invested in Immunovant in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

2.15% more ownership

Funds ownership: 34.45%36.59% (+2.1%)

9% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
112
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.18M
Puts
$614K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$55M
2
$30M
3
$24.3M
4
$22.3M
5
$19.6M
6
$11M
7
$9.85M
8
$5.91M
9
$4.9M
10
$4.54M
11
$4.53M
12
$3.68M
13
$3.27M
14
$3.23M
15
$1.97M
16
$1.95M
17
$1.9M
18
$1.7M
19
$1.67M
20
$1.44M
21
$1.37M
22
$1.28M
23
$1.23M
24
$1.18M
25
$995K